Financials
Financial year 2025
X - PHARMA from Verviers, company number BE0449256092, closed financial year 2025 with a result of € 9,962 after tax. For that financial year X - PHARMA recorded a gross margin of € 15,417 and equity of € 148,387. Compared with financial year 2024, the result moved from € 17,556 to € 9,962. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 6, 2026.
€ 148,387
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,962
▼ 43% vs 2024
Profit after tax over the fiscal year.
€ 93,051
▲ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 86,387.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 951
▼ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 812
▼ 76% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 15,738 | € 14,072 | € 15,485 | € 15,417 | |
| Profit after taxes | € 10,385 | € 9,173 | € 17,556 | € 9,962 | ▼ 43% |
| Equity | € 116,183 | € 120,869 | € 138,425 | € 148,387 | ▲ 7% |
| Total debts | € 1,353 | € 6,476 | € 4,739 | € 1,763 | ▼ 63% |
| Cash | € 52,899 | € 50,406 | € 80,204 | € 93,051 | ▲ 16% |
| Retained profit | € 54,183 | € 58,869 | € 76,425 | € 86,387 | ▲ 13% |
| Dividend | € 0 | € 4,488 | € 0 | € 0 | |
| Balance sheet total | € 117,536 | € 127,344 | € 143,164 | € 150,150 | ▲ 5% |
By gross margin, X - PHARMA ranks 13th of 14 companies with main activity “Detailhandel in farmaceutische producten” in Verviers that publish figures (fiscal year 2025).
Key figures of X - PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about X - PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to X - PHARMA?
What happened at X - PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jean François CLASSEN stepped down as director. NBB
- MARIE-ODILE Renier stepped down as director. NBB
- Aurélie CLASSEN stepped down as director. NBB
- Alain CLASSEN stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 9,962 (▼ 43% vs 2024). Source: NBB ↗
- Jean François CLASSEN became a director. NBB
- MARIE-ODILE Renier became a director. NBB
- Aurélie CLASSEN became a director. NBB
In short
From € 10,385 profit in 2022 to € 9,962 profit in 2025.
Paid € 21,626 in corporate taxes since 2022.
Best year ever: 2024, with € 17,556 profit.
Paid out € 4,488 in dividends to the owners in total.
Management
Directors
According to the 2025 annual accounts
Jean François CLASSEN
Director
since 2023 · until 2029
since 2023 · until 2029
Aurélie CLASSEN
Director
since 2023 · until 2029
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Place de Petit-Rechain 21
4800 Verviers
Rue du Bief 16
4652 Herve
Active since 10 March 1993
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Verviers
Same main activity (Detailhandel in farmaceutische producten), 16 active companies in Verviers, largest first.
€ 411,085 gross margin · 2025
€ 370,741 gross margin · 2025
€ 302,084 gross margin · 2025
€ 228,344 gross margin · 2025
€ 226,172 gross margin · 2025
€ 180,198 gross margin · 2025
Details
- Company number
- 0449.256.092
- VAT number
- BE 0449.256.092
- Registered office
- Place de Petit-Rechain 21, 4800 Verviers
- Names & denominations
- X - PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 January 1993
- Peppol
- Active · Active since 15 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers